Trial Profile
An Open Label Pilot Study to Evaluate the Efficacy of PAC-14028 in the Treatment of Erythematotelangiectatic Rosacea and Papulopustular Rosacea
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jan 2017
Price :
$35
*
At a glance
- Drugs Asivatrep (Primary) ; Metronidazole
- Indications Rosacea
- Focus Therapeutic Use
- Sponsors AmorePacific
- 10 Jan 2017 New trial record